| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Viridian Therapeutics, Inc.\DE | 10%+ Owner | Common Stock | 1.51M | $31.6M | $21.00 | 23 Sep 2021 | Direct |
| Adverum Biotechnologies, Inc. | 10%+ Owner | Common Stock | 0 | $0 | $3.56 | 09 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ADVM | Adverum Biotechnologies, Inc. | 09 Dec 2025 | 1 | -$15.3M | 4 | 09 Dec 2025 | 10%+ Owner |
| ADVM | Adverum Biotechnologies, Inc. | 25 Nov 2025 | 0 | $0 | 3 | 05 Dec 2025 | 10%+ Owner |
| VRDN | Viridian Therapeutics, Inc.\DE | 23 Sep 2021 | 1 | $2.2M | 4 | 28 Sep 2021 | 10%+ Owner |
| VRDN | Viridian Therapeutics, Inc.\DE | 16 Aug 2021 | 0 | $0 | 3 | 26 Aug 2021 | 10%+ Owner |